Core Laboratories (CLB) Operating Leases (2022 - 2026)

Core Laboratories' Operating Leases history runs 5 years deep, the most recent figure standing at $41.3 million for Q1 2026.

• On a quarterly basis, Operating Leases fell 6.13% year-over-year to $41.3 million in Q1 2026; TTM through Mar 2026 was $41.3 million, a 6.13% decrease from a year earlier, with the FY2025 full-year figure at $42.3 million, down 2.39% from the prior year.
• Operating Leases declined to $41.3 million in Q1 2026 per CLB's latest filing, from $42.3 million in the prior quarter.
• Across five years, Operating Leases topped out at $44.0 million in Q1 2025 and bottomed at $38.3 million in Q4 2022.
• The 5-year median for Operating Leases is $42.3 million (2025), against an average of $42.0 million.
• Across the five-year window, Operating Leases rose 9.84% in 2023 and declined 6.13% in 2026, its largest moves.
• Year by year, Operating Leases stood at $38.3 million in 2022, then rose by 9.84% to $42.1 million in 2023, then grew by 3.01% to $43.3 million in 2024, then retreated by 2.39% to $42.3 million in 2025, then declined by 2.42% to $41.3 million in 2026.
• Per Business Quant, the three latest CLB Operating Leases figures stand at $41.3 million (Q1 2026), $42.3 million (Q4 2025), and $41.5 million (Q3 2025).